Loading...

Frederick J Meyers, MD; MACP

Title(s)Professor, Internal Medicine
SchoolUniversity of California, Davis
Address2450 48th Street, ASB Suite 2800, Room 2832
CA 95817
Phone916-734-2412
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Frontiers of University Training to Unlock the Research Enterprise (FUTURE)
    NIH DP7OD018426Sep 20, 2013 - Aug 31, 2018
    Role: Principal Investigator
    K30 Mentored Clinical research Training Program
    NIH/NCRR K30RR022264Sep 19, 2005 - Jun 30, 2010
    Role: Principal Investigator
    Simultaneous Care: Linking Palliation to Clinical Trials
    NIH/NCI R25CA095260Jul 25, 2002 - Jun 30, 2009
    Role: Principal Investigator
    TRAUMA REDUCTION IN END OF LIFE DECISION MAKING
    NIH/NIA R03AG017391Aug 1, 1999 - Jul 31, 2001
    Role: Principal Investigator
    WEST COAST CENTER FOR PALLIATIVE MEDICINE EDUCATION
    NIH/NCI R25CA067068Sep 30, 1994 - Aug 31, 1998
    Role: Principal Investigator
    Southwest Oncology Group/University of California, Davis
    NIH/NCI U10CA046441Jan 1, 1988 - Dec 31, 2015
    Role: Co-Principal Investigator
    NORTHERN CALIFORNIA ONCOLOGY GROUP
    NIH/NCI U10CA025838Aug 1, 1983 - Jul 31, 1987
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. High Versus Low Volume Fluid Resuscitation Strategies in a Porcine Model (Sus Scrofa) of Combined Thermal and Traumatic Brain Injury. Shock. 2020 Aug 31. Guenther TM, Spruce MW, Bach LM, Caples CM, Beyer CA, Grayson JK, Meyers FJ, Palmieri TL, Brown IE. PMID: 32881757.
      View in: PubMed   Mentions:    Fields:    
    2. Building a comprehensive mentoring academy for schools of health. J Clin Transl Sci. 2019 Oct; 3(5):211-217. Schweitzer JB, Rainwater JA, Ton H, Giacinto RE, Sauder CAM, Meyers FJ. PMID: 31660245.
      View in: PubMed   Mentions:
    3. Hospital utilization and disposition among patients with malignant bowel obstruction: a population-based comparison of surgical to medical management. BMC Cancer. 2018 Nov 26; 18(1):1166. Bateni SB, Gingrich AA, Stewart SL, Meyers FJ, Bold RJ, Canter RJ. PMID: 30477454.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    4. Palliative Care Training and Decision-Making for Patients with Advanced Cancer: A Comparison of Surgeons and Medical Physicians. Surgery. 2018 Apr 27. Bateni SB, Canter RJ, Meyers FJ, Galante JM, Bold RJ. PMID: 29709369.
      View in: PubMed   Mentions: 2     Fields:    
    5. Comparison of common risk stratification indices to predict outcomes among stage IV cancer patients with bowel obstruction undergoing surgery. J Surg Oncol. 2018 Mar; 117(3):479-487. Bateni SB, Bold RJ, Meyers FJ, Canter DJ, Canter RJ. PMID: 29044598.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    6. Lung resection is safe and feasible among stage IV cancer patients: An American College of Surgeons National Surgical Quality Improvement Program analysis. Surgery. 2017 05; 161(5):1307-1314. Bateni SB, David EA, Bold RJ, Cooke DT, Meyers FJ, Canter RJ. PMID: 28011006.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    7. Increased Rates of Prolonged Length of Stay, Readmissions, and Discharge to Care Facilities among Postoperative Patients with Disseminated Malignancy: Implications for Clinical Practice. PLoS One. 2016; 11(10):e0165315. Bateni SB, Meyers FJ, Bold RJ, Canter RJ. PMID: 27780274.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    8. Editorial--Accelerating precision oncology in the 21st century. Surg Oncol. 2015 Dec; 24(4):359-60. Meyers TJ, Meyers FJ. PMID: 26608412.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. The origin and implementation of the Broadening Experiences in Scientific Training programs: an NIH common fund initiative. FASEB J. 2016 Feb; 30(2):507-14. Meyers FJ, Mathur A, Fuhrmann CN, O'Brien TC, Wefes I, Labosky PA, Duncan DS, August A, Feig A, Gould KL, Friedlander MJ, Schaffer CB, Van Wart A, Chalkley R. PMID: 26432783.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    10. Three Dimensional Culture of Human Renal Cell Carcinoma Organoids. PLoS One. 2015; 10(8):e0136758. Batchelder CA, Martinez ML, Duru N, Meyers FJ, Tarantal AF. PMID: 26317980.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    11. Transforming training to reflect the workforce. Sci Transl Med. 2015 Apr 29; 7(285):285ed4. Mathur A, Meyers FJ, Chalkley R, O'Brien TC, Fuhrmann CN. PMID: 25925677.
      View in: PubMed   Mentions: 7     Fields:    
    12. Current perioperative outcomes for patients with disseminated cancer. J Surg Res. 2015 Jul; 197(1):118-25. Bateni SB, Meyers FJ, Bold RJ, Canter RJ. PMID: 25911950.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    13. Graduate medical education reform: moving the elephant. J Gen Intern Med. 2014 Nov; 29(11):1434-5. Meyers FJ, Henderson MC. PMID: 24981781.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. A transparent oversight policy for human anatomical specimen management: the University of California, Davis experience. Acad Med. 2014 Mar; 89(3):410-4. Schmitt B, Wacker C, Ikemoto L, Meyers FJ, Pomeroy C. PMID: 24448034.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    15. Training the translational research teams of the future: UC Davis-HHMI Integrating Medicine into Basic Science program. Clin Transl Sci. 2013 Oct; 6(5):339-46. Knowlton AA, Rainwater JA, Chiamvimonvat N, Bonham AC, Robbins JA, Henderson S, Meyers FJ. PMID: 24127920.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    16. Restructuring academic health centers to advance interdisciplinary collaborations: opportunities for psychiatry departments. Acad Psychiatry. 2013 Mar 01; 37(2):72-5. Meyers FJ, Hales RE, Young HM, Nesbitt TS, Pomeroy C. PMID: 23475231.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Commentary: decentralizing quality improvement. Am J Med Qual. 2013 May-Jun; 28(3):261-2. Shaikh U, Meyers FJ. PMID: 23042916.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. Strengthening the career development of clinical translational scientist trainees: a consensus statement of the Clinical Translational Science Award (CTSA) Research Education and Career Development Committees. Clin Transl Sci. 2012 Apr; 5(2):132-7. Meyers FJ, Begg MD, Fleming M, Merchant C. PMID: 22507118.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    19. "Teaching as a Competency": competencies for medical educators. Acad Med. 2011 Oct; 86(10):1211-20. Srinivasan M, Li ST, Meyers FJ, Pratt DD, Collins JB, Braddock C, Skeff KM, West DC, Henderson M, Hales RE, Hilty DM. PMID: 21869655.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    20. Creating the future biomedical research workforce. Sci Transl Med. 2011 Sep 28; 3(102):102fs5. Meyers FJ, Pomeroy C. PMID: 21957169.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    21. Nomogram to predict risk of 30-day morbidity and mortality for patients with disseminated malignancy undergoing surgical intervention. Ann Surg. 2011 Aug; 254(2):333-8. Tseng WH, Yang X, Wang H, Martinez SR, Chen SL, Meyers FJ, Bold RJ, Canter RJ. PMID: 21677562.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    22. A model for rural oncology. J Oncol Pract. 2011 May; 7(3):168-71. Heifetz LJ, Christensen SD, Devere-White RW, Meyers FJ. PMID: 21886498.
      View in: PubMed   Mentions: 3     Fields:    
    23. Palliative care in urology. Surg Clin North Am. 2011 Apr; 91(2):429-44, x. Wu JN, Meyers FJ, Evans CP. PMID: 21419262.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. Effects of a problem-solving intervention (COPE) on quality of life for patients with advanced cancer on clinical trials and their caregivers: simultaneous care educational intervention (SCEI): linking palliation and clinical trials. J Palliat Med. 2011 Apr; 14(4):465-73. Meyers FJ, Carducci M, Loscalzo MJ, Linder J, Greasby T, Beckett LA. PMID: 21413846.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    25. Recombinant innovation and translational science trainees. Sci Transl Med. 2010 Jul 07; 2(39):39ed5. Meyers FJ. PMID: 20610848.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    26. Radical palliative surgery: new limits to pursue. Pediatr Surg Int. 2009 Oct; 25(10):917-21. Young-Spint M, Guner YS, Meyers FJ, Schneider P, Khatri VP. PMID: 19718542.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    27. Palliative and End-of-Life Care in Correctional Settings. Journal of Social Work in End-of-Life & Palliative Care. 2009 Sep 17; 5(1-2):7-33. John F. Linder, Frederick J. Meyers. .
      View in: Publisher Site   Mentions:
    28. Cardiovascular disease in women--challenges deserving a comprehensive translational approach. J Cardiovasc Transl Res. 2009 Sep; 2(3):251-5. Lee JS, Bertakis K, Meyers FJ, Chedin E, Tarantal A, Anderson K, Berglund L. PMID: 19655023.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    29. Probiotics and immunity. J Gastroenterol. 2009; 44(1):26-46. Borchers AT, Selmi C, Meyers FJ, Keen CL, Gershwin ME. PMID: 19159071.
      View in: PubMed   Mentions: 99     Fields:    Translation:HumansAnimalsCells
    30. The utility of the model for end-stage liver disease score: a reliable guide for liver transplant candidacy and, for select patients, simultaneous hospice referral. Liver Transpl. 2008 Aug; 14(8):1100-6. Medici V, Rossaro L, Wegelin JA, Kamboj A, Nakai J, Fisher K, Meyers FJ. PMID: 18668666.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    31. Integrating palliative care in severe chronic obstructive lung disease. COPD. 2008 Aug; 5(4):207-20. Hardin KA, Meyers F, Louie S. PMID: 18671146.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    32. Treatment options for muscle-invasive urothelial cancer for patients who were not eligible for cystectomy or neoadjuvant chemotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin: report of Southwest Oncology Group Trial 8733. Cancer. 2008 May 15; 112(10):2181-7. Higano CS, Tangen CM, Sakr WA, Faulkner J, Rivkin SE, Meyers FJ, Hussain M, Baker LH, Russell KJ, Crawford ED. PMID: 18404692.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    33. Diverse populations can use hospice services appropriately. Am J Med. 2008 Apr; 121(4):e1-2. Meyers FJ, Lin A, Sribney WM, Aguilar-Gaxiola S. PMID: 18374668.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    34. The immunobiology of mushrooms. Exp Biol Med (Maywood). 2008 Mar; 233(3):259-76. Borchers AT, Krishnamurthy A, Keen CL, Meyers FJ, Gershwin ME. PMID: 18296732.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimalsCells
    35. Racial and ethnic differences in treatment and survival among adults with primary extremity soft-tissue sarcoma. Cancer. 2008 Mar 01; 112(5):1162-8. Martinez SR, Robbins AS, Meyers FJ, Bold RJ, Khatri VP, Goodnight JE. PMID: 18213619.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    36. On reversing the persistence of memory: hematopoietic stem cell transplant for autoimmune disease in the first ten years. J Autoimmun. 2008 May; 30(3):180-96. Deane S, Meyers FJ, Gershwin ME. PMID: 18242059.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    37. Redesigning residency training in internal medicine: the consensus report of the Alliance for Academic Internal Medicine Education Redesign Task Force. Acad Med. 2007 Dec; 82(12):1211-9. Meyers FJ, Weinberger SE, Fitzgibbons JP, Glassroth J, Duffy FD, Clayton CP. PMID: 18046131.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    38. Palliative care for prison inmates: "don't let me die in prison". JAMA. 2007 Aug 22; 298(8):894-901. Linder JF, Meyers FJ. PMID: 17712073.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    39. Can patient coaching reduce racial/ethnic disparities in cancer pain control? Secondary analysis of a randomized controlled trial. Pain Med. 2007 Jan-Feb; 8(1):17-24. Kalauokalani D, Franks P, Oliver JW, Meyers FJ, Kravitz RL. PMID: 17244100.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    40. Redesigning training for internal medicine. Ann Intern Med. 2006 Dec 05; 145(11):865-6; author reply 866. Fitzgibbons JP, Meyers FJ. PMID: 17146075.
      View in: PubMed   Mentions: 2     Fields:    
    41. Endoscopic ultrasound-guided celiac plexus neurolysis for pancreatic cancer pain: a single-institution experience and review of the literature. J Support Oncol. 2006 Oct; 4(9):460-2, 464; discussion 463-4. Tran QN, Urayama S, Meyers FJ. PMID: 17080734.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    42. Patient desires: a model for assessment of patient preferences for care of severe or terminal illness. Palliat Support Care. 2005 Dec; 3(4):289-99. Knops KM, Srinivasan M, Meyers FJ. PMID: 17039984.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    43. Confronting the brutal facts in health care. Am J Med. 2005 Oct; 118(10):1061-3. Henderson MC, Meyers FJ, Ibrahim T, Tierney LM. PMID: 16194632.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    44. Medical and surgical palliative care of patients with urological malignancies. J Urol. 2005 Oct; 174(4 Pt 1):1177-82. Ok JH, Meyers FJ, Evans CP. PMID: 16145365.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    45. The Palliative Care in Assisted Living (PCAL) pilot study: successes, shortfalls, and methodological implications. Soc Sci Med. 2006 Jan; 62(1):199-207. Jerant AF, Azari RS, Nesbitt TS, Edwards-Goodbee A, Meyers FJ. PMID: 15987662.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    46. Extending palliative care is there a role for preventive medicine? J Palliat Med. 2005 Jun; 8(3):486-9. Zwerdling T, Hamann K, Meyers F. PMID: 15992188.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    47. Closing the gap between internal medicine training and practice: Recommendations from recent graduates. Am J Med. 2005 Jun; 118(6):680-5; discussion 685-7. Arora V, Guardiano S, Donaldson D, Storch I, Hemstreet P. PMID: 15922702.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    48. An approach to develop effective health care decision making for women in prison. J Palliat Med. 2005 Apr; 8(2):432-9. Enders SR, Paterniti DA, Meyers FJ. PMID: 15890054.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    49. Simultaneous care: a model approach to the perceived conflict between investigational therapy and palliative care. J Pain Symptom Manage. 2004 Dec; 28(6):548-56. Meyers FJ, Linder J, Beckett L, Christensen S, Blais J, Gandara DR. PMID: 15589080.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    50. An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California. Cancer J. 2004 Sep-Oct; 10(5):294-300. Martel CL, Li Y, Beckett L, Chew H, Christensen S, Davies A, Lam KS, Lau DH, Meyers FJ, O'donnell RT, Richman C, Scudder S, Tanaka M, Tuscano J, Welborn J, Wun T, Gandara DR, Lara PN. PMID: 15530258.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    51. A strategy for the simultaneous provision of pre-operative palliative care for patients awaiting liver transplantation. Transpl Int. 2004 Sep; 17(8):473-5. Rossaro L, Troppmann C, McVicar JP, Sturges M, Fisher K, Meyers FJ. PMID: 15322744.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    52. Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: final results from the California Cancer Consortium Screening and Phase II Trial. Cancer. 2004 May 15; 100(10):2125-31. Lara PN, Chee KG, Longmate J, Ruel C, Meyers FJ, Gray CR, Edwards RG, Gumerlock PH, Twardowski P, Doroshow JH, Gandara DR. PMID: 15139054.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCellsCTClinical Trials
    53. Laser Treatment of Endobronchial Renal Cell Carcinoma. Journal of Bronchology & Interventional Pulmonology. 2004 Apr 1; 11(2):92-97. Andrew L. Chan, Maya M. Juarez, Timothy E. Albertson, Brian M. Morrissey, Roblee P. Allen, Frederick J. Meyers. .
      View in: Publisher Site   Mentions:
    54. Adjuvant therapy of osteosarcoma--A Phase II trial: Southwest Oncology Group study 9139. Cancer. 2004 Feb 15; 100(4):818-25. Zalupski MM, Rankin C, Ryan JR, Lucas DR, Muler J, Lanier KS, Budd GT, Biermann JS, Meyers FJ, Antman K. PMID: 14770440.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    55. Platinum-free combination chemotherapy in patients with advanced or metastatic transitional cell carcinoma. Cancer. 2004 Jan 01; 100(1):82-8. Lara PN, Meyers FJ, Law LY, Dawson NA, Houston J, Lauder I, Edelman MJ. PMID: 14692027.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    56. The TLC model of palliative care in the elderly: preliminary application in the assisted living setting. Ann Fam Med. 2004 Jan-Feb; 2(1):54-60. Jerant AF, Azari RS, Nesbitt TS, Meyers FJ. PMID: 15053284.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    57. Centers, institutes, and the future of clinical departments: Part II. Am J Med. 2003 Dec 15; 115(9):745-7. Crist TB, LaRusso NF, Meyers FJ, Clayton CP, Ibrahim T. PMID: 14693335.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    58. SU5416 plus interferon alpha in advanced renal cell carcinoma: a phase II California Cancer Consortium Study with biological and imaging correlates of angiogenesis inhibition. Clin Cancer Res. 2003 Oct 15; 9(13):4772-81. Lara PN, Quinn DI, Margolin K, Meyers FJ, Longmate J, Frankel P, Mack PC, Turrell C, Valk P, Rao J, Buckley P, Wun T, Gosselin R, Galvin I, Gumerlock PH, Lenz HJ, Doroshow JH, Gandara DR. PMID: 14581348.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCellsCTClinical Trials
    59. Centers, Institutes, and the future of clinical departments: part I. Am J Med. 2003 Sep; 115(4):337-41. Ibrahim T, O'Connell JB, LaRusso NF, Meyers FJ, Crist TB. PMID: 14509279.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    60. Population-based maximum tolerated dose of irinotecan and carboplatin. Oncology (Williston Park). 2003 Jul; 17(7 Suppl 7):11-6. Wild CA, Wang SE, Gandara DR, Lara PN, Meyers FJ, Tanaka M, Houston J, Lauder J, Lau DH. PMID: 12886868.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    61. Current strategies in the management of hormone refractory prostate cancer. Cancer Treat Rev. 2003 Jun; 29(3):171-87. Martel CL, Gumerlock PH, Meyers FJ, Lara PN. PMID: 12787712.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    62. Simultaneous care: disease treatment and palliative care throughout illness. J Clin Oncol. 2003 Apr 01; 21(7):1412-5. Meyers FJ, Linder J. PMID: 12663735.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    63. Prison hospice and pastoral care services in California. J Palliat Med. 2002 Dec; 5(6):903-8. Linder JF, Knauf K, Enders SR, Meyers FJ. PMID: 12685537.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    64. Does HER2/neu expression provide prognostic information in patients with advanced urothelial carcinoma? Cancer. 2002 Sep 01; 95(5):1009-15. Gandour-Edwards R, Lara PN, Folkins AK, LaSalle JM, Beckett L, Li Y, Meyers FJ, DeVere-White R. PMID: 12209684.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    65. Hospice care for the incarcerated in the United States: an introduction. J Palliat Med. 2002 Aug; 5(4):549-52. Linder JF, Enders SR, Craig E, Richardson J, Meyers FJ. PMID: 12243679.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    66. HER-2/neu is overexpressed infrequently in patients with prostate carcinoma. Results from the California Cancer Consortium Screening Trial. Cancer. 2002 May 15; 94(10):2584-9. Lara PN, Meyers FJ, Gray CR, Edwards RG, Gumerlock PH, Kauderer C, Tichauer G, Twardowski P, Doroshow JH, Gandara DR. PMID: 12173324.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    67. Surgery for emphysema. N Engl J Med. 2002 Mar 14; 346(11):860-2. Meyers FJ. PMID: 11898808.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    68. Combined modality radioimmunotherapy for human prostate cancer xenografts with taxanes and 90yttrium-DOTA-peptide-ChL6. Prostate. 2002 Jan 01; 50(1):27-37. O'Donnell RT, DeNardo SJ, Miers LA, Lamborn KR, Kukis DL, DeNardo GL, Meyers FJ. PMID: 11757033.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimals
    69. Radioimmunotherapy with (111)In/(90)Y-2IT-BAD-m170 for metastatic prostate cancer. Clin Cancer Res. 2001 Jun; 7(6):1561-8. O'Donnell RT, DeNardo SJ, Yuan A, Shen S, Richman CM, Lara PN, Griffith IJ, Goldstein DS, Kukis DL, Martinez GS, Mirick GR, DeNardo GL, Meyers FJ. PMID: 11410491.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCTClinical Trials
    70. Individualized patient education and coaching to improve pain control among cancer outpatients. J Clin Oncol. 2001 Apr 15; 19(8):2206-12. Oliver JW, Kravitz RL, Kaplan SH, Meyers FJ. PMID: 11304773.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCTClinical Trials
    71. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol. 2001 Mar 15; 19(6):1728-33. Lara PN, Higdon R, Lim N, Kwan K, Tanaka M, Lau DH, Wun T, Welborn J, Meyers FJ, Christensen S, O'Donnell R, Richman C, Scudder SA, Tuscano J, Gandara DR, Lam KS. PMID: 11251003.
      View in: PubMed   Mentions: 165     Fields:    Translation:Humans
    72. Correspondence re: G. C. de Gast et al., Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma. Clin. Cancer Res., 6: 1267-1272, 2000. Clin Cancer Res. 2000 Oct; 6(10):4167. Meyers FJ, O' Donnell RT. PMID: 11051273.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    73. Efficacy and toxicity of radioimmunotherapy with (90)Y-DOTA-peptide-ChL6 for PC3-tumored mice. Prostate. 2000 Aug 01; 44(3):187-92. O'Donnell RT, DeNardo SJ, DeNardo GL, Miers L, Lamborn KR, Kukis DL, Meyers FJ. PMID: 10906734.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    74. Phase I/II study of paclitaxel, carboplatin, and methotrexate in advanced transitional cell carcinoma: a well-tolerated regimen with activity independent of p53 mutation. Urology. 2000 Apr; 55(4):521-5. Edelman MJ, Meyers FJ, Miller TR, Williams SG, Gandour-Edwards R, deVere White RW. PMID: 10736495.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    75. Suramin therapy for patients with symptomatic hormone-refractory prostate cancer: results of a randomized phase III trial comparing suramin plus hydrocortisone to placebo plus hydrocortisone. J Clin Oncol. 2000 Apr; 18(7):1440-50. Small EJ, Meyer M, Marshall ME, Reyno LM, Meyers FJ, Natale RB, Lenehan PF, Chen L, Slichenmyer WJ, Eisenberger M. PMID: 10735891.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCTClinical Trials
    76. Molecular biology of prostate carcinogenesis. Crit Rev Oncol Hematol. 1999 Dec; 32(3):197-208. Lara PN, Kung HJ, Gumerlock PH, Meyers FJ. PMID: 10633849.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    77. Serotonergic blockade in the treatment of the cancer anorexia-cachexia syndrome. Cancer. 1999 Aug 15; 86(4):684-8. Edelman MJ, Gandara DR, Meyers FJ, Ishii R, O'Mahony M, Uhrich M, Lauder I, Houston J, Gietzen DW. PMID: 10440697.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    78. Cellular drug interaction in the fight against multidrug resistant cancer. Crit Care Med. 1999 Feb; 27(2):244-5. Albertson TE, Meyers F. PMID: 10075036.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    79. Palliative education: a didactic and experiential approach to teaching end-of-life care. J Cancer Educ. 1999; 14(3):154-60. Linder JF, Blais J, Enders SR, Melberg SE, Meyers FJ. PMID: 10512332.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    80. Treatment options in androgen-independent prostate cancer. Cancer Invest. 1999; 17(2):137-44. Lara PN, Meyers FJ. PMID: 10071598.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    81. Perspectives on palliative care: a chair of medicine viewpoint. J Palliat Med. 1999; 2(4):371-5. Meyers FJ. PMID: 15859776.
      View in: PubMed   Mentions:    Fields:    
    82. Very frequent p53 mutations in metastatic prostate carcinoma and in matched primary tumors. Cancer. 1998 Dec 15; 83(12):2534-9. Meyers FJ, Gumerlock PH, Chi SG, Borchers H, Deitch AD, deVere White RW. PMID: 9874460.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    83. L6 monoclonal antibody binds prostate cancer. Prostate. 1998 Oct 01; 37(2):91-7. O'Donnell RT, DeNardo SJ, Shi XB, Mirick GR, DeNardo GL, Kroger LA, Meyers FJ. PMID: 9759703.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    84. Expanded phase II trial of paclitaxel in metastatic breast cancer: a Southwest Oncology Group study. Breast Cancer Res Treat. 1998 Sep; 51(2):169-81. Geyer CE, Green SJ, Moinpour CM, O'Sullivan J, Goodwin DK, Canfield VA, Meyers FJ, Osborne CK, Martino S. PMID: 9879778.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    85. Prostate carcinoma: clarification through clinical insight and molecular diagnostics. West J Med. 1998 Jun; 168(6):525. Meyers FJ, DeVere White RW. PMID: 9655997.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    86. Follow-up testing after cancer treatment: is it indicated? West J Med. 1998 Jun; 168(6):528-9. Edelman MJ, Siegel D, Meyers F. PMID: 9656000.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    87. Increased RB1 abnormalities in human primary prostate cancer following combined androgen blockade. Prostate. 1998 Feb 01; 34(2):145-51. Mack PC, Chi SG, Meyers FJ, Stewart SL, deVere White RW, Gumerlock PH. PMID: 9465946.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    88. Phase I trial of edatrexate plus carboplatin in advanced solid tumors: amelioration of dose-limiting mucositis by ice chip cryotherapy. Invest New Drugs. 1998; 16(1):69-75. Edelman MJ, Gandara DR, Perez EA, Lau D, Lauder I, Turrell C, Uhrich M, Meyers F. PMID: 9740546.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    89. Phase II trial of edatrexate in relapsed or refractory germ cell tumors: a Southwest Oncology Group study (SWOG 9124). Invest New Drugs. 1998-1999; 16(4):347-51. Meyers FJ, Lew D, Lara PN, Williamson S, Marshall E, Balcerzak SP, Rivkin SE, Samlowski W, Crawford ED. PMID: 10426670.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    90. Phase II trial of pyrazine diazohydroxide in androgen-independent prostate cancer. Invest New Drugs. 1998; 16(2):179-82. Edelman MJ, Meyers FJ, Grennan T, Lauder J, Doroshow J. PMID: 9848583.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    91. Enhancement of 67Cu-2IT-BAT-LYM-1 therapy in mice with human Burkitt's lymphoma (Raji) using interleukin-2. Cancer. 1997 Dec 15; 80(12 Suppl):2576-82. DeNardo GL, Kukis DL, DeNardo SJ, Shen S, Mausner LF, O'Donnell RT, Lamborn KR, Meyers FJ, Srivastava SC, Miers LA. PMID: 9406712.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    92. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma. Semin Oncol. 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. Edelman MJ, Meyers FJ, Houston J, Lauder I. PMID: 9346226.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    93. Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22. J Clin Oncol. 1997 May; 15(5):1858-69. Fisher B, Anderson S, Wickerham DL, DeCillis A, Dimitrov N, Mamounas E, Wolmark N, Pugh R, Atkins JN, Meyers FJ, Abramson N, Wolter J, Bornstein RS, Levy L, Romond EH, Caggiano V, Grimaldi M, Jochimsen P, Deckers P. PMID: 9164196.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCTClinical Trials
    94. The utility of follow-up testing after curative cancer therapy. A critical review and economic analysis. J Gen Intern Med. 1997 May; 12(5):318-31. Edelman MJ, Meyers FJ, Siegel D. PMID: 9159703.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    95. A study of reproductive function in patients with seminoma treated with radiotherapy and orchidectomy: (SWOG-8711). Southwest Oncology Group. Int J Radiat Oncol Biol Phys. 1997 Apr 01; 38(1):83-94. Gordon W, Siegmund K, Stanisic TH, McKnight B, Harris IT, Carroll PR, Paradelo JC, Meyers FJ, Chapman RA, Meyskens FL. PMID: 9212008.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    96. Giant carcinoid tumor of the lung. Ann Thorac Surg. 1997 Mar; 63(3):851-2. Sheppard BB, Follette DM, Meyers FJ. PMID: 9066421.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    97. Human androgen receptor expression in prostate cancer following androgen ablation. Eur Urol. 1997; 31(1):1-6. de Vere White R, Meyers F, Chi SG, Chamberlain S, Siders D, Lee F, Stewart S, Gumerlock PH. PMID: 9032526.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    98. NM23 gene expression in human prostatic carcinomas and benign prostatic hyperplasias: altered expression in combined androgen blockaded carcinomas. J Urol. 1996 Jun; 155(6):2080-4. Borchers H, Meyers FJ, Gumerlock PH, Stewart SL, deVere White RW. PMID: 8618340.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    99. Combination transurethral resection, systemic chemotherapy, and pelvic radiotherapy for invasive (T2-T4) bladder cancer unsuitable for cystectomy: a phase I/II Southwestern Oncology Group study. Urology. 1996 May; 47(5):652-7. Einstein AB, Wolf M, Halliday KR, Miller GJ, Hafermann M, Lowe BA, Meyers FJ, Leimert JT, Crawford ED. PMID: 8650861.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    100. Phase II trial of CHIP for the treatment of advanced, hormonally refractory carcinoma of the prostate. A Southwest Oncology Group Study. Am J Clin Oncol. 1995 Oct; 18(5):400-2. Marshall ME, Wolf MK, Crawford ED, Weiss GR, Ahmann F, Meyers FJ, Blumenstein B, Eisenberger M, Einstein AB. PMID: 7572756.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    101. Screening for cancer. Is it worth it? West J Med. 1995 Aug; 163(2):166-8. Meyers FJ. PMID: 7571573.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    102. Carboplatin infusion in relapsed and refractory acute myeloid leukemia--a Southwest Oncology Group trial. Leukemia. 1995 Jul; 9(7):1126-9. Welborn JL, Kopecky KJ, Meyers FJ, Veith R, Shurafa M, Doroshow JH, Balcerzak SP, Appelbaum FR. PMID: 7630183.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    103. Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study. J Clin Oncol. 1995 Jun; 13(6):1303-11. Leichman CG, Fleming TR, Muggia FM, Tangen CM, Ardalan B, Doroshow JH, Meyers FJ, Holcombe RF, Weiss GR, Mangalik A. PMID: 7751875.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCTClinical Trials
    104. Evaluation of low dose alpha-interferon (Roferon-A) in patients with advanced renal cell carcinoma: a Southwest Oncology Group study. Cancer Biother. 1995; 10(3):205-9. Marshall ME, Wolf M, Crawford ED, Thompson IM, Flanigan R, Balcerzak SP, Meyers FJ. PMID: 8547959.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    105. A phase II trial of concomitant interferon-alpha-2b and granulocyte-macrophage colony-stimulating factor in patients with advanced renal cell carcinoma. J Immunother Emphasis Tumor Immunol. 1995 Jan; 17(1):58-61. O'Donnell RT, Dea G, Meyers FJ. PMID: 7728306.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    106. Quantitation of NM23 expression in human prostate tissues. J Urol. 1994 Jul; 152(1):202-7. Fishman JR, Gumerlock PH, Meyers FJ, deVere White RW. PMID: 7515452.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    107. p53 in prostate cancer: frequent expressed transition mutations. J Natl Cancer Inst. 1994 Jun 15; 86(12):926-33. Chi SG, deVere White RW, Meyers FJ, Siders DB, Lee F, Gumerlock PH. PMID: 7515114.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    108. Prostate cancer screening. Ann Intern Med. 1994 Jun 15; 120(12):1052; author reply 1053. Godley PA. PMID: 7514368.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    109. p53 mutations in benign prostatic hyperplasia. J Natl Cancer Inst. 1993 Nov 17; 85(22):1856-8. Meyers FJ, Chi SG, Fishman JR, deVere White RW, Gumerlock PH. PMID: 7693956.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    110. Rapid PCR construction of a gene containing Lym-1 antibody variable regions. PCR Methods Appl. 1993 Aug; 3(1):46-53. Shi XB, Gumerlock PH, Wellman AA, Meares CF, DeNardo GL, Meyers FJ, DeNardo SJ. PMID: 8220184.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    111. Prolonged, alternating chemotherapy for extensive small cell lung cancer. A Southwest oncology Group study. Cancer. 1993 Jun 01; 71(11):3509-13. Livingston RB, Crowley JJ, Thompson T, Williamson SK, Meyers FJ, O'Rourke T, Neefe JR. PMID: 8387881.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    112. Phase II trial of echinomycin for the treatment of advanced renal cell carcinoma. A Southwest Oncology Group study. Invest New Drugs. 1993 May-Aug; 11(2-3):207-9. Marshall ME, Wolf MK, Crawford ED, Taylor S, Blumenstein B, Flanigan R, Meyers FJ, Hynes HE, Barlogie B, Eisenberger M. PMID: 8262733.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    113. Polyethylene glycol conjugated interleukin-2: clinical and immunologic effects in patients with advanced renal cell carcinoma. Invest New Drugs. 1993 May-Aug; 11(2-3):211-7. Bukowski RM, Young J, Goodman G, Meyers F, Issell BF, Sergi JS, McLain D, Fyfe G, Finke J. PMID: 8262734.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    114. Phase I study of antilipopolysaccharide human monoclonal antibody MAB-T88. Antimicrob Agents Chemother. 1992 Oct; 36(10):2349-51. Daifuku R, Haenftling K, Young J, Groves ES, Turrell C, Meyers FJ. PMID: 1444318.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    115. Combination cisplatin and dichloromethotrexate in patients with advanced bladder cancer. Phase 2. A Southwest Oncology Group study. J Urol. 1992 Jul; 148(1):52-4. Meyers FJ, Blumenstein B, Crawford ED, Hynes HE, Montie JE, Taylor SA, Grossman HB, Natale RB. PMID: 1613880.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    116. Suppression and transient induction of lymphokines in cancer patients after administration of polyethylene glycolated interleukin-2. Eur J Immunol. 1992 Mar; 22(3):727-33. Shih Y, Konrad MW, Warren MK, Childs A, Paradise C, Meyers FJ, Groves ES. PMID: 1547819.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    117. Urinary prostate specific antigen levels: role in monitoring the response of prostate cancer to therapy. J Urol. 1992 Mar; 147(3 Pt 2):947-51. DeVere White RW, Meyers FJ, Soares SE, Miller DG, Soriano TF. PMID: 1371566.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    118. Use of the polymerase chain reaction for the specific and direct detection of Clostridium difficile in human feces. Rev Infect Dis. 1991 Nov-Dec; 13(6):1053-60. Gumerlock PH, Tang YJ, Meyers FJ, Silva J. PMID: 1775837.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    119. Bladder cancer. Human leukocyte antigen II, interleukin-6, and interleukin-6 receptor expression determined by the polymerase chain reaction. Cancer. 1991 Apr 15; 67(8):2087-95. Meyers FJ, Gumerlock PH, Kawasaki ES, Wang AM, deVere White RW, Erlich HA. PMID: 2004327.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    120. Activated ras alleles in human carcinoma of the prostate are rare. Cancer Res. 1991 Mar 15; 51(6):1632-7. Gumerlock PH, Poonamallee UR, Meyers FJ, deVere White RW. PMID: 1998954.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    121. A phase I study including pharmacokinetics of polyethylene glycol conjugated interleukin-2. Clin Pharmacol Ther. 1991 Mar; 49(3):307-13. Meyers FJ, Paradise C, Scudder SA, Goodman G, Konrad M. PMID: 2007324.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCTClinical Trials
    122. A three-point approach to anemia. Postgrad Med. 1991 Feb 01; 89(2):179-83, 186. Welborn JL, Meyers FJ. PMID: 1990391.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    123. Weekly 24-hour continuous infusion interleukin-2 for metastatic melanoma and renal cell carcinoma: a phase I study. J Immunother (1991). 1991 Feb; 10(1):57-62. Perez EA, Scudder SA, Meyers FA, Tanaka MS, Paradise C, Gandara DR. PMID: 2012799.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    124. An outpatient approach to the delivery of intensive consolidation chemotherapy to adults with acute lymphoblastic leukemia. Oncol Nurs Forum. 1990 Jul-Aug; 17(4):553-8. Palmer P, Meyers FJ. PMID: 2399168.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    125. Prognosis in disseminated prostate cancer as related to tumor ploidy and differentiation. World Journal of Urology. 1990 Mar 1; 8(1):47-50. Ralph W. deVere White, Arline D. Deitch, Henry Tesluk, Kathleen R. Lamborn, Frederick J. Meyers. .
      View in: Publisher Site   Mentions:
    126. High-dose cisplatin and mitomycin C in advanced non-small cell lung cancer: a phase II study of the Northern California Oncology Group. Cancer Chemother Pharmacol. 1990; 27(3):243-7. Gandara DR, Perez EA, Wold H, Caggiano V, Malec M, Ahn DK, Meyers F, Carlson RW. PMID: 2176134.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    127. ras p21 expression in ovine pulmonary carcinoma. Vet Immunol Immunopathol. 1989 Dec; 23(3-4):279-91. Meyers FJ, Madewell BR, Gumerlock PH, DeMartini JC. PMID: 2697961.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    128. Sequential flow cytometry and single gene analysis by enzymatic amplification and allele specific oligonucleotide hybridization of urothelial cells. J Urol. 1989 Dec; 142(6):1599-601. Meyers FJ, Gumerlock PH, Teplitz RL, Hatcher SL, deVere White RW. PMID: 2585644.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    129. Canine and bovine ras family expression detected and discriminated by use of polymerase chain reaction. Anticancer Res. 1989 Nov-Dec; 9(6):1743-9. Madewell BR, Gumerlock PH, Saunders KA, Meyers FJ, Kraegel SA, Kawasaki ES. PMID: 2483304.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    130. Partial splenic embolization guided by blood flow measurements. Invest Radiol. 1989 Sep; 24(9):678-83. Link DP, Lantz BM, Seibert JA, Meyers FJ. PMID: 2807821.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    131. Intraventricular morphine administered by hospice nurses to a patient with intractable pain. Am J Hosp Care. 1989 Jul-Aug; 6(4):36-9. Carlisle DW, Smith KA, Frank E, Meyers FJ. PMID: 2604982.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    132. RAS enzyme-linked immunoblot assay discriminates p21 species: a technique to dissect gene family expression. Anal Biochem. 1989 Jul; 180(1):158-68. Gumerlock PH, Meyers FJ, Kokoris SP, Wong G, McCormick FP, de Vere White RW. PMID: 2683857.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    133. Human bladder and colon carcinomas contain activated ras p21. Specific detection of twelfth codon mutants. Cancer. 1989 Jun 01; 63(11):2177-81. Meyers FJ, Gumerlock PH, Kokoris SP, deVere White RW, McCormick F. PMID: 2655864.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    134. Cisplatin dose intensity in non-small cell lung cancer: phase II results of a day 1 and day 8 high-dose regimen. J Natl Cancer Inst. 1989 May 10; 81(10):790-4. Gandara DR, Wold H, Perez EA, Deisseroth AB, Doroshow J, Meyers F, McWhirter K, Hannigan J, De Gregorio MW. PMID: 2541260.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    135. Infusion carboplatin treatment of relapsed and refractory acute leukemia: evidence of efficacy with minimal extramedullary toxicity at intermediate doses. J Clin Oncol. 1989 Feb; 7(2):173-8. Meyers FJ, Welborn J, Lewis JP, Flynn N. PMID: 2644396.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    136. Activated c-N-ras in radiation-induced acute nonlymphocytic leukemia: twelfth codon aspartic acid. Radiat Res. 1989 Feb; 117(2):198-206. Gumerlock PH, Meyers FJ, Foster BA, Kawakami TG, deVere White RW. PMID: 2646654.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    137. Development of monoclonal antibody imaging of metastatic prostatic carcinoma. Prostate. 1989; 14(3):209-20. Meyers FJ, Denardo SJ, Macey D, White RD, Unger M. PMID: 2471962.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    138. Impact of reinduction regimens on the clinical course of adult acute nonlymphocytic leukemia. Leukemia. 1988 Nov; 2(11):711-6. Welborn JL, Lewis JP, Meyers FJ. PMID: 3054348.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    139. Improved approach to patients with normocytic anemia. Am Fam Physician. 1988 Aug; 38(2):191-5. Meyers FJ, Welborn JL, Lewis JP. PMID: 3407586.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    140. c-H-ras-1 expression in 7,12-dimethyl benzanthracene-induced Balb/c mouse mammary hyperplasias and their tumors. Oncogene. 1988 Aug; 3(2):205-13. Cardiff RD, Gumerlock PH, Soong MM, Dandekar S, Barry PA, Young LJ, Meyers FJ. PMID: 2842717.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    141. Human renal clear cell carcinoma: establishment and characterization of a new cell line (G-2101). In Vitro Cell Dev Biol. 1988 May; 24(5):429-34. Gumerlock PH, Edwards BF, Deitch AD, Meyers FJ. PMID: 2453501.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    142. Renal salt wasting and carboplatinum. Ann Intern Med. 1988 Apr; 108(4):640. Welborn J, Meyers FJ, O'Grady LF. PMID: 3279897.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    143. Alpha-interferon in superficial bladder cancer: a Northern California Oncology Group Study. J Clin Oncol. 1988 Mar; 6(3):476-83. Torti FM, Shortliffe LD, Williams RD, Pitts WC, Kempson RL, Ross JC, Palmer J, Meyers F, Ferrari M, Hannigan J. PMID: 3280742.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    144. Prostatic-specific antigen: clinical experience utilizing immunoperoxidase staining techniques in patients with metastatic prostate cancer. J Surg Oncol. 1988 Mar; 37(3):165-7. Baker WC, Meyers FJ, White RW. PMID: 2451087.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    145. Epithelial membrane antigen expression in benign and malignant squamous epithelium of the head and neck. Otolaryngol Head Neck Surg. 1987 Sep; 97(3):288-93. Fernandez B, Lund J, Meyers F. PMID: 3118310.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    146. Management of chronic pain. Am Fam Physician. 1987 Jul; 36(1):139-46. Meyers FJ, Meyers FH. PMID: 2440292.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    147. Cisplatin, doxorubicin, and 5-fluorouracil chemotherapy for salivary gland malignancies: a pilot study of the Northern California Oncology Group. J Clin Oncol. 1987 Jun; 5(6):951-5. Venook AP, Tseng A, Meyers FJ, Silverberg I, Boles R, Fu KK, Jacobs CD. PMID: 3585449.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    148. Mast cell disease followed by leukemia with clonal evolution. Leuk Res. 1987; 11(9):769-73. Lewis JP, Welborn JL, Meyers FJ, Levy NB, Roschak T. PMID: 3118098.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    149. High-dose VP-16 with intermediate-dose cytosine arabinoside in the treatment of relapsed acute nonlymphocytic leukemia. Cancer Chemother Pharmacol. 1987; 20(3):265-6. Chan HY, Meyers FJ, Lewis JP. PMID: 3677301.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    150. The integration of cytogenetic analysis into the evaluation of cryptic exudative effusions. Cancer. 1986 Oct 01; 58(7):1479-83. Meyers FJ, Lewis JP, Marianos S. PMID: 3742465.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    151. A focused approach to patients with cancer of unknown primary site. West J Med. 1986 Sep; 145(3):403-4. Meyers FJ, Lewis JP. PMID: 3765625.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    152. Identification of unsuspected thyroid carcinoma using immunoperoxidase for thyroglobulin. Am J Med. 1986 Jul; 81(1):177-9. Meyers FJ, Goodnight JE. PMID: 3524223.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    153. Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsy. Cancer Res. 1986 Jul; 46(7):3722-7. Torti FM, Bristow MM, Lum BL, Carter SK, Howes AE, Aston DA, Brown BW, Hannigan JF, Meyers FJ, Mitchell EP. PMID: 3458531.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    154. Epirubicin in non-oat cell lung cancer--response rates and the importance of immunopathology: a Northern California Oncology Group Study. Cancer Treat Rep. 1986 Jun; 70(6):805-6. Meyers FJ, Cardiff RD, Quadro R, Gribble M, Kohler M, Medrano V, Mitchell EP, Shiffman R, William L. PMID: 2425963.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    155. Tumor biology in explanation of the failure of screening for cancer and in determination of future strategies. Am J Med. 1986 May; 80(5):911-6. Meyers FJ. PMID: 3706378.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    156. The resolution of phenotypic ambiguity in a case of human leukemia using cytogenetics and immunoglobulin gene rearrangement. Am J Clin Pathol. 1986 Mar; 85(3):372-4. Meyers FJ, Miller CH, Lewis JP. PMID: 3019121.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    157. A phase II study of cisplatin and cytosine arabinoside for recurrent squamous cell carcinoma of the head and neck. Am J Clin Oncol. 1986 Feb; 9(1):58-60. Bernstein JI, Jacobs C, Meyers F, Rich-Goffinet L, Tanaka L. PMID: 3953492.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    158. The fate of the bladder in patients with metastatic bladder cancer treated with cisplatin, methotrexate and vinblastine: a Northern California Oncology Group study. J Urol. 1985 Dec; 134(6):1118-21. Meyers FJ, Palmer JM, Freiha FS, Harker EG, Shortliffe LD, Hannigan J, McWhirter K, Torti FM. PMID: 3903223.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    159. Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study. J Clin Oncol. 1985 Nov; 3(11):1463-70. Harker WG, Meyers FJ, Freiha FS, Palmer JM, Shortliffe LD, Hannigan JF, McWhirter KM, Torti FM. PMID: 4056840.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    160. Daunomycin administered by continuous intravenous infusion is effective in the treatment of acute nonlymphocytic leukaemia. Br J Haematol. 1985 Oct; 61(2):261-5. Lewis JP, Meyers FJ, Tanaka L. PMID: 4041369.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    161. Chronic myelogenous leukemia and breaks at 9q34. Cancer Genet Cytogenet. 1985 Aug; 17(4):367-8. Lewis JP, Meyers FJ. PMID: 3860284.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    162. Phase II trial of 4'-epi-doxorubicin in advanced colorectal carcinoma: a Northern California Oncology Group study. Cancer Treat Rep. 1985 Jan; 69(1):143-4. Meyers FJ, Lewis B, Mitchell E, William L, Hannigan JF, Gribble M, Torti FM. PMID: 3855385.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    163. Phase II trial of 4'-epi-doxorubicin in metastatic melanoma. Cancer Treat Rep. 1984 Dec; 68(12):1509-10. Torti FM, Porzig KJ, Gandara DR, Volberding P, Mitchell E, Meyers FJ, Kohler M, Gribble M. PMID: 6595059.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    164. Hairy cell leukemia has a B-cell genotype. Hematol Oncol. 1984 Apr-Jun; 2(2):145-50. Meyers FJ, Cardiff RD, Taylor CR, Zuniga M, Radich J. PMID: 6430776.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    165. A randomized phase III study of cisplatin with or without methotrexate for recurrent squamous cell carcinoma of the head and neck. A Northern California Oncology Group study. Cancer. 1983 Nov 01; 52(9):1563-9. Jacobs C, Meyers F, Hendrickson C, Kohler M, Carter S. PMID: 6352004.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    166. Penile cancer chemotherapy. Recent Results Cancer Res. 1983; 85:143-7. Meyers FJ. PMID: 6191370.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    167. Case 42-1981: Hodgkin's disease. N Engl J Med. 1982 May 06; 306(18):1115. Meyers FJ, Lewis JP, Marianos S. PMID: 7070416.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells